FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

FHIR IG Statistics (1516 ms)

Resources - All Kinds, Realm EU, Authority Hl7

1038 resources

Type:
Text: Use quotation marks (") for an exact phrase. You can use AND, OR, and NOT. Wildcard = *

By Version

Prev Rows 200 - 400 Next
PackageVersionIdentityName/TitleStatusDate
hl7.eu.fhir.fluteR4ConceptMap/CM-StudyVariables2FHIR Study variables Model to FHIR R4 Mapdraft2023-12
hl7.eu.fhir.fluteR4ConceptMap/InclusionCriterias2FHIR Concept Map for Inclusion Criteria to FHIRdraft2024-05
hl7.eu.fhir.fluteR4ImplementationGuide/hl7.eu.fhir.flute FLUTE Cross-border Prostate Cancer Data Standard Guidedraft2024-09
hl7.eu.fhir.fluteR4Questionnaire/Questionnaire-StudyVariable Study variable Extractionactive2024-03
hl7.eu.fhir.fluteR4StructureDefinition/InclusionCriterias Inclusion Criteria for Prostate Cancer Cohortsdraft2024-09
hl7.eu.fhir.fluteR4StructureDefinition/PR-Biopsy Procedure: biopsydraft2024-09
hl7.eu.fhir.fluteR4StructureDefinition/PR-DigitalRectalExamination Procedure: DREdraft2024-09
hl7.eu.fhir.fluteR4StructureDefinition/PR-OutcomeBCN-RC2 Observation: Outcome BCN-RC 2draft2024-09
hl7.eu.fhir.fluteR4StructureDefinition/PR-PIRADSScore Observation: PI-RADSdraft2024-09
hl7.eu.fhir.fluteR4StructureDefinition/PR-ProstateCancerFamilyHistory FamilyMemberHistory: prostate cancer family historydraft2024-09
hl7.eu.fhir.fluteR4StructureDefinition/PR-ProstateSpecificAntigen Observation: prostate specific antigendraft2024-09
hl7.eu.fhir.fluteR4StructureDefinition/PR-ProstateVolume Observation: prostate volumedraft2024-09
hl7.eu.fhir.fluteR4StructureDefinition/StudyVariables Prostate Cancer study Variablesdraft2024-09
hl7.eu.fhir.fluteR4StructureDefinition/documentReference-eu-flute DocumentReference: link with variablesdraft2024-09
hl7.eu.fhir.fluteR4StructureDefinition/imagingStudy-eu-flute ImagingStudy: link with variablesdraft2024-09
hl7.eu.fhir.fluteR4StructureDefinition/resource-supportingInfo Resource supporting informationdraft2024-09
hl7.eu.fhir.fluteR4TestScript/TS-Flute-01 Study Inclusion Criteria - Scenario 01draft2024-09
hl7.eu.fhir.fluteR4TestScript/TS-Flute-02 Study Inclusion Criteria - Scenario 02draft2024-09
hl7.eu.fhir.fluteR4TestScript/TS-Flute-03 This TestScript is designed to validate the populate of a questionnairedraft2024-05
hl7.eu.fhir.fluteR4TestScript/TS-Flute-04 This TestScript is designed to validate the extract of a questionnaire responsedraft2024-05
hl7.eu.fhir.fluteR4TestScript/TS-Flute-05 This TestScript is designed to validate the cql library ResearchVariables2draft2024-06
hl7.eu.fhir.fluteR4ValueSet/VS-BiopsyType Type of Biopsydraft2024-09
hl7.eu.fhir.fluteR4ValueSet/VS-DREOutcomeCode DRE Observation Interpretation Codesdraft2024-09
hl7.eu.fhir.fluteR4ValueSet/VS-GleasonGrade Gleason Gradedraft2024-09
hl7.eu.fhir.fluteR4ValueSet/VS-PCa Malignant tumor of prostate Value Setdraft2024-09
hl7.eu.fhir.fluteR4ValueSet/VS-PiRads Prostate Imaging – Reporting and Data Systemdraft2024-09
hl7.fhir.eu.epsR4ConceptMap/patientSummary2FHIR eHN Patient Summary to this guide Mapdraft2024-12
hl7.fhir.eu.epsR4ConceptMap/subjectPs2FHIR eHN Subject to this guide Mapdraft2024-12
hl7.fhir.eu.epsR4ImplementationGuide/hl7.fhir.eu.eps HL7 Europe Patient Summarydraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/Allergy A.2.1.1 - Allergydraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/ClosedProblem A.2.2.2 - Resolved, closed or inactive problemsdraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/FunctionalStatus A.2.3.3 - Functional Statusdraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/MedicalDevice A.2.3.2 - Medical devices and implantsdraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/Medication-eu-eps Medication (EPS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/MedicationStatement-eu-eps Medication Statement (EU PS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/Medicine A.2.4.1 Current and relevant past medicinesdraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/PatientSummary A - Patient Summarydraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/Pregnancy A.2.6 Pregnancy historydraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/Problem A.2.3.1 Current problemsdraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/ProcedurePs A.2.3.3 - Proceduresdraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/Result A.2.8 - Resultsdraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/Subject A1.1, A1.2 - Subject of caredraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/Vaccination A.2.2.1 - Vaccination/ prophylaxis informationdraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/allergyIntolerance-eu-eps Allergy Intolerance (EU PS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/bundle-eu-eps Bundle (EU PS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/composition-eu-eps Composition (EU PS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/condition-eu-eps Condition (EU PS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/condition-statusReason Condition Status Reasondraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/device-eu-eps Device (EPS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/deviceUseStatement-eu-eps DeviceUseStatement (EPS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/flag-eu-eps Flag (EU PS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/immunization-administeredProduct Immunization AdministeredProductdraft2024-12
hl7.fhir.eu.epsR4StructureDefinition/medicationRequest-eu-eps MedicationRequest (EPS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/organization-eu-eps Organization (EU PS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/patient-eu-eps Patient (EU PS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/practitioner-eu-eps Practitioner (EU PS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/practitionerRole-eu-eps PractitionerRole: (EU PS)draft2024-12
hl7.fhir.eu.epsR4StructureDefinition/supportingInformation Supporting Informationdraft2024-12
hl7.fhir.eu.epsR4ValueSet/medical-devices-eu-hdr Medical Devices (SNOMED CT) - Xpandhdraft2024-12
hl7.fhir.eu.epsR4ValueSet/medical-devices-snomed-absent-unknown-eu-hdr Medical Devices - SNOMED CT + Absent/Unknown - IPSdraft2024-12
hl7.eu.fhir.xshareR4ImplementationGuide/hl7.eu.fhir.xshare xShare Projectdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5ImplementationGuide/hl7.eu.fhir.xt-ehr.foundation Xt-EHRdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/AD ADdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/ANY ANYdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/BL BLdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/CD CDdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/Class Classdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/DT DTdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/EN ENdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/INT INTdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/InstanceIdentifier IIdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/PQ PQdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/QT QTdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/REAL REALdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/RTO RTOdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/ST STdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/TS TSdraft2024-12
hl7.eu.fhir.xt-ehr.foundationR5StructureDefinition/Untyped Untypeddraft2024-12
hl7.eu.fhir.xpandh.mpdR4ConceptMap/eP2FHIR-eu-xpandh eHN Subject to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.mpdR4ConceptMap/medProd2FHIR-eu-xpandh eHN Medicinal Product to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.mpdR4ImplementationGuide/hl7.eu.fhir.xpandh.mpd XpanDH Project Medication (e)Prescription and (e)Dispensationdraft2024-12
hl7.eu.fhir.xpandh.mpdR4StructureDefinition/Medication-ep-eu-xpandh Medication: XpanDHdraft2024-12
hl7.eu.fhir.xpandh.mpdR4StructureDefinition/MedicationDispense-eu-xpandh MedicationDispense: XpanDHdraft2024-12
hl7.eu.fhir.xpandh.mpdR4StructureDefinition/MedicationRequest-eu-xpandh MedicationRequest: XpanDHdraft2024-12
hl7.eu.fhir.xpandh.mpdR4StructureDefinition/MedicinalProduct A1.4 Identification of the prescribed productdraft2024-12
hl7.eu.fhir.xpandh.mpdR4StructureDefinition/Patient-eu-xpandh Patient: XpanDHdraft2024-12
hl7.eu.fhir.xpandh.mpdR4StructureDefinition/Practitioner-eu-xpandh Practitionerdraft2024-12
hl7.eu.fhir.xpandh.mpdR4StructureDefinition/PractitionerRole-eu-xpandh PractitionerRoledraft2024-12
hl7.eu.fhir.xpandh.mpdR4StructureDefinition/Prescription A - Prescriptiondraft2024-12
hl7.eu.fhir.xpandh.mpdR4StructureDefinition/Subject A.1.1 Patient administrative datadraft2024-12
hl7.eu.fhir.ghR5CapabilityStatement/capabilityStatement FOSPS FHIR G-Lens serviceactive2023-12
hl7.eu.fhir.ghR5CodeSystem/LensCategoriesCodes LensCategoriesCodesactive2024-12
hl7.eu.fhir.ghR5CodeSystem/asm-category-cs Category of ASMactive2024-12
hl7.eu.fhir.ghR5CodeSystem/epicategory-cs Category of EPIactive2024-12
hl7.eu.fhir.ghR5CodeSystem/icpc-2-cs Example ICPC2 CSactive2024-12
hl7.eu.fhir.ghR5CodeSystem/pd-category-cs Persona Vector Dimensions categoriesactive2024-12
hl7.eu.fhir.ghR5CodeSystem/pd-type-cs Persona Vector Dimensions Codeactive2024-12
hl7.eu.fhir.ghR5CodeSystem/questi-dimens-cs Questionnaire example Dimensionsactive2024-12
hl7.eu.fhir.ghR5CodeSystem/type-of-data-cs Type of information to be added in epi CSactive2024-12
hl7.eu.fhir.ghR5ConceptMap/country-iso-spor SNOMED CT to ICD-10-CM mappings for fracture of ulnadraft2012-06
hl7.eu.fhir.ghR5ConceptMap/domain-spor-hl7 SNOMED CT to ICD-10-CM mappings for fracture of ulnadraft2012-06
hl7.eu.fhir.ghR5ConceptMap/legalstatussupply-hl7-spor SNOMED CT to ICD-10-CM mappings for fracture of ulnadraft2012-06
hl7.eu.fhir.ghR5ImplementationGuide/hl7.eu.fhir.gh Gravitate Health FHIR Implementation Guideactive2024-12
hl7.eu.fhir.ghR5OperationDefinition/-s-ai-summary Ai-summaryactive2024-12
hl7.eu.fhir.ghR5OperationDefinition/annotate annotateactive2024-12
hl7.eu.fhir.ghR5OperationDefinition/diff Diffactive2024-12
hl7.eu.fhir.ghR5OperationDefinition/focus focusactive2024-12
hl7.eu.fhir.ghR5http://gravitate-health.com/SearchParameter/composition-category composition-categoryactive2024-12
hl7.eu.fhir.ghR5StructureDefinition/AdditionalSupportMaterial Additional Support Material Profileactive2024-12
hl7.eu.fhir.ghR5StructureDefinition/HtmlElementLink HtmlElementLinkactive2024-12
hl7.eu.fhir.ghR5StructureDefinition/LensesApplied LensesAppliedactive2024-12
hl7.eu.fhir.ghR5StructureDefinition/ProvenanceGH Provenance Profileactive2024-12
hl7.eu.fhir.ghR5StructureDefinition/RelatedMedicalIssue RelatedMedicalIssueactive2024-12
hl7.eu.fhir.ghR5StructureDefinition/SummaryData Summary Data Profileactive2024-12
hl7.eu.fhir.ghR5StructureDefinition/VisualizationMethod VisualizationMethodactive2024-12
hl7.eu.fhir.ghR5StructureDefinition/blockchain-transaction-id Blockchain Transaction IDactive2024-12
hl7.eu.fhir.ghR5StructureDefinition/focusedcomposition Focused Composition Profileactive2024-12
hl7.eu.fhir.ghR5StructureDefinition/lee-version LEEversionactive2024-12
hl7.eu.fhir.ghR5StructureDefinition/lens Lens Profileactive2024-12
hl7.eu.fhir.ghR5StructureDefinition/persona-collection Persona Dimension Collectionactive2024-12
hl7.eu.fhir.ghR5ValueSet/3point-category-vs ThreepointCategoryVSactive2024-12
hl7.eu.fhir.ghR5ValueSet/LensCategories LensCategoriesactive2024-12
hl7.eu.fhir.ghR5ValueSet/PDcategoryVS PDcategoryVSactive2024-12
hl7.eu.fhir.ghR5ValueSet/PDtypeVS PDtypeVSactive2024-12
hl7.eu.fhir.ghR5ValueSet/asm-category-vs ASMCategoryVSactive2024-12
hl7.eu.fhir.ghR5ValueSet/type-of-data-vs TypeOfDataVSactive2024-12
hl7.eu.fhir.idea4rcR4CodeSystem/cs-generic-eu-i4rc IDEA4RC Code Systemdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/adverseEvent2FHIR Radiotherapy Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/cancerEpisode2FHIR Cancer Episode Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/episodeEvent2FHIR Episode Event Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/followup2FHIR Patient Follow up Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/geneticTest2FHIR Genetic Test to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/geneticTestExpression2FHIR Genetic Test Expression Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/hNstage2FHIR HN Stage Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/hospitalPatientRecords2FHIR Hospital Patient Records Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/otherTreatment2FHIR Other Treatment to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/radiotherapy2FHIR Radiotherapy Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/sarcomaStage2FHIR Stage Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/subject2FHIR Subject Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ConceptMap/surgery2FHIR Surgery Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcR4ImplementationGuide/hl7.eu.fhir.idea4rc IDEA4RC FHIR Implementation Guidedraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/AdverseEvent Adverse Eventdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/Bundle-eu-i4rc Bundle: IDEA4RCdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/CancerEpisode Cancer Episodedraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/Condition-primaryCancer-eu-i4rc Condition: Primary Cancerdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/Condition-secondaryCancer-eu-i4rc Condition: Metastatic Cancerdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/Encounter-eu-i4rc Encounter: IDEA4RCdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/EpisodeEvent Episode Eventdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/GeneticTestExpression Genetic Test Expressiondraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/HnStage Head Neck Stagedraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/HospitalPatientRecords Hospital Patient Recordsdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/MedicationAdministration-eu-i4rc MedicationAdministration: Chemotherapydraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/Observation-diagnosis-eu-i4rc Observation: Diagnosis detailsdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/OtherTreatment Other Local Treatmentdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/PathologicalReportInfo Pathological Report Infodraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/PatientFollowUp Patient Follow Updraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/Procedure-otherTreatment-eu-i4rc Procedure: Other Treatmentdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/Procedure-radiotheraphy-eu-i4rc Procedure: Radiotherapydraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/Procedure-surgery-eu-i4rc Procedure: Surgerydraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/Race-eu-i4rc Race Extensiondraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/Radiotherapy Radiotherapydraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/SarcomaStage Sarcoma Stagedraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/Subject Subject of caredraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/Surgery Surgerydraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/SystemicTreatment Systemic Treatmentdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/TreatmentResponse Treatment Responsedraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/adverseEvent-eu-i4rc AdverseEvent: IDEA4RCdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/condition-previousStatus Previous Statusdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/condition-relapseType Relapse Typedraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/episodeOfCare-eu-i4rc EpisodeOfCare: IDEA4RCdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/hn-cancer-stage-group Observation: Head Neck Cancer Stage Groupdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/mcode-body-location-qualifier Body Location Qualifierdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/mcode-condition-related Condition related to resourcedraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/mcode-laterality-qualifier Laterality Qualifierdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/mcode-radiotherapy-dose-delivered-to-volume Radiotherapy Dose Delivered To Volume Extensiondraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/mcode-radiotherapy-modality-and-technique Radiotherapy Modality And Technique Extensiondraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/mcode-radiotherapy-modality Radiotherapy Modality Extensiondraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/mcode-radiotherapy-sessions Radiotherapy Number of Sessions Extensiondraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/mcode-radiotherapy-technique Radiotherapy Technique Extensiondraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/mcode-tnm-distant-metastases-category Observation: TNM Distant Metastases Categorydraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/mcode-tnm-primary-tumor-category Observation: TNM Primary Tumor Categorydraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/mcode-tnm-regional-nodes-category Observation: TNM Regional Nodes Categorydraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-alcoholuse-eu-i4rc Observation: Alcohol usedraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-cci-eu-i4rc Observation: Charlson Comorbidity Indexdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-comorbidity-eu-i4rc Observation: Comorbiditiesdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-dateLastContact-eu-i4rc Observation: date of the last contactdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-ecog-performance-status-eu-i4rc Observation: ECOG Performance Statusdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-extraNodalExtension-eu-i4rc Observation: Radiological Extra-nodal extension (rENE)draft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-karnofsky-performance-statuseu-i4rc Observation: Karnofsky Performance Statusdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-lastFollowupStatus-eu-i4rc Observation: Status at the Last Follow Updraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-occurrencOtherCancer-eu-i4rc Observation: Occurrence of the other cancerdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-testResult-eu-i4rc Observation: test resultsdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-tobaccouse-eu-i4rc Observation: Tobacco usedraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-treatment-eu-i4rc Observation: Cancer Treatmentdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/observation-yesNo-eu-i4rc Observation: Yes / No assertionsdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/patient-eu-i4rc Patient: IDEA4RCdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/procedure-performedTiming Performed Timingdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/radiotherapy-energy-or-isotope Radiotherapy Energy or Isotopedraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/same-custodian-flag Same custodian flagdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/sarcoma-cancer-stage-group Observation: Sarcoma Cancer Stage Groupdraft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/sarcoma-extent-category Observation: Localized Category (Stage, Sarcoma)draft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/sarcoma-locoRegional-category Observation: LocoRegional Category (Stage, Sarcoma)draft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/Gender-i4rc Gender: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/alcoholUsageStatus-athena-eu-i4rc Alcohol Usage Status: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/alcoholUsageStatus-snomed-eu-i4rc Alcohol Usage Status: SNOMED CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/beam-quality-i4rc Beam Qualityactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-chondroOsseousTumours-athena-vs Cancer Chondro Osseous Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-diagnosis-athena-vs Cancer diagnosis: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-estAndRelatedTumours-athena-vs Cancer Endometrial stromal and related Tumors: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-event-type-vs Cancer Event Type: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologyAdenocarcinoma-athena-vs Cancer Histology Adenocarcinoma: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologyNeuroendocrine-athena-vs Cancer Histology Neuroendocrine: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologyOdontogenicCarcinoma-athena-vs Cancer Histology Odontogenic Carcinoma: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologySNUC-athena-vs Cancer Histology SNUC: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologySquamous-athena-vs Cancer Histology Squamous: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologySubgroupAdipocyticTumours-athena-vs Cancer Histology Subgroup Adipocytic Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologySubgroupFmtTumours-athena-vs Cancer Histology Subgroup Fmt Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-miscellaniousMesenchimalTumors-athena-vs Cancer Miscellanious mesenchimal tumors: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-mixedEpithelialAndMesenchymalTumours-athena-vs Cancer Mixed epithelial and mesenchymal tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-pericyticPerivascularTumours-athena-vs Cancer Pericytic Perivascular Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-peripheralNerveSheathTumours-athena-vs Cancer Peripheral Nerve Sheath Tumors: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-skeletalMuscleTumours-athena-vs Cancer Skeletal Muscle Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-smoothMuscleTumours-athena-vs Cancer Smooth Muscle Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-socalledFibrohistiocyticTumours-athena-vs Cancer Histology Subgroup So called Fibrohistiocytic Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-stageGrading-athena-vs Cancer Stage Grading: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-stageGroup-athena-vs Cancer Stage Group: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-stageGroupValue-athena-vs Cancer Stage Group Value: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-tumoursOfUncertainDifferentiation-athena-vs Cancer Tumors Of Uncertain Differentiation: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-undifSmallRCelSarcBonAndSofTis-athena-vs Cancer undif. small round cell sarcomas of bone and soft tissue: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-vascularTumours-athena-vs Cancer Vascular Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/chemo-units-eu-i4rc Chemotherapy cumulative dose unitsdraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/comorbidities-athena-eu-i4rc Comorbidities: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/comorbidities-sct-eu-i4rc Comorbidities: SNOMEDactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/country-eu-i4rc Country: athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/disease-extent-category-vs Sarcoma Staging: localized diseasedraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/drugsAtc-eu-i4rc Antineoplastic and immunostimulating agentsdraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/ecog-i4rc ECOG Performance Statusactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/event-type-eu-i4rc Event Typeactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/extranodal-extension-i4rc Extranodal Extensiondraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/geneticTestPerformed-eu-i4rc Genetic Tests performed (Yes/no/Unk)active2024-11
hl7.eu.fhir.idea4rcR4ValueSet/genito-urinary-subsite-athena-i4rc Genito urinary subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/hypopharynx-subsite-athena-i4rc Hypopharynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/hypopharynx-subsite-sct-i4rc Hypopharynx subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/intra-abdominal-subsite-athena-i4rc Intra abdominal subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/intra-thoracic-subsite-athena-i4rc Intra thoracic subsite : Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/larynx-subsite-athena-i4rc Larynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/larynx-subsite-sct-i4rc Larynx subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/lip-subsite-athena-i4rc Lip subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/lip-subsite-sct-i4rc Lip subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/locoregional-category-vs Sarcoma Staging: loco-regional categorydraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/margins-after-surgery-eu-i4rc Margins After Surgeryactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-distant-metastases-category-vs TNM Distant Metastases Category Value Setdraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-primary-tumor-category-vs TNM Primary Tumor Category Value Setdraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-regional-nodes-category-vs TNM Regional Nodes Category Value Setdraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/metastasis-disorder-athena-vs Metastatis: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/nasal-paranasal-subsite-athena-i4rc Nasal cavity and paranasal sinuses subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/nasal-paranasal-subsite-sct-i4rc Nasal cavity and paranasal sinuses subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/nasal-subsite-athena-i4rc Subsites: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/nasal-subsite-sct-i4rc Subsites: SNOMED CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/nasopharynx-subsite-athena-i4rc Nasopharynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/nasopharynx-subsite-sct-i4rc Nasopharynx subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/obsYesNo-code-eu-i4rc Types of Yes/No observationsactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/occurrence-other-cancer-i4rc Occurrence of other canceractive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/oralCavity-subsite-athena-i4rc Oral cavity subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/oralCavity-subsite-sct-i4rc Oral cavity subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/oropharynx-subsite-athena-i4rc Oropharynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/oropharynx-subsite-sct-i4rc Oropharynx subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/pathologicalM-i4rc Pathological Mactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/pathologicalN-i4rc Pathological Nactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/pathologicalT-i4rc Pathological Tactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/pos-neg-nt-athena-eu-i4rc Positive-Negative-No Test: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/race-i4rc Raceactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/reason-for-end-of-treatment-eu-i4rc Reason For End Of Treatmentactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/setting-radiotherapy-i4rc Setting Radiotherapyactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/simpleResult-eu-i4rc Simple measuresactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/site-of-metastasis-i4rc Site of metastasisactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/site-qualifier-i4rc Body site qualifieractive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/siteRare-i4rc Site rare (IDEA4RC)active2024-11
hl7.eu.fhir.idea4rcR4ValueSet/smokingStatus-athena-eu-i4rc Current Smoking Status: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/smokingStatus-loinc-eu-i4rc Smoking Status: LOINCactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/status-last-followup-i4rc Status at the Last Follow Upactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/surgery-complication-eu-i4rc Surgery Complicationactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/surgery-intention-eu-i4rc Surgery Intentionactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/surgery-outcome-eu-i4rc Surgery Outcomeactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/surgical-complications-eu-i4rc Surgical Complicationsactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/tobacco-product-eu-i4rc Tobacco Productactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/treatment-completed-as-planned-i4rc Treatment completed as plannedactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/treatment-response-eu-i4rc Treatment Responseactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/treatment-setting-eu-i4rc Treatment Settingactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/treatment-technique-i4rc Treatment Techniqueactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/trunk-wall-subsite-athena-i4rc Trunk wall subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/type-of-biopsy-eu-i4rc Type of Biopsyactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/type-of-diagnosis-eu-i4rc Type of Diagnosisactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/type-of-surgical-approach-eu-i4rc Type of surgical approachactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/type-of-systemic-treatment-eu-i4rc Type of Systemic Treatmentactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/type-of-treatment-eu-i4rc Type of Treatmentactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/upperLower-limbs-subsite-athena-i4rc Upper and Lower limbs subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/vs-affectedOrgan-eu-i4rc Affected Organs (surgery)active2024-11
hl7.eu.fhir.idea4rcR4ValueSet/vs-calcest-eu-i4rc Calculated|Estimateddraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/vs-npunk-eu-i4rc Not Performed|Unknowndraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/vs-radiotherapyDeviceType-eu-i4rc Radiotherapy Device Typedraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/vs-surgicalProcedureCategory-eu-i4rc Surgical Procedure Categoryactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/vs-surgicalProcedureType-eu-i4rc Surgical Procedure Typeactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/yes-no-unk-athena-eu-i4rc Yes-No-Unk: Athenaactive2024-11
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000093533 ATC Human EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000072052 Marketing Status EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000008 Combination Package EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000006 Combined Pharmaceutical Dose Form EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000007 Combined Term EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000000002 Country EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000000004 Domain EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000072057 Language EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000072051 Legal Status for the Supply EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000003199 Material EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000073346 Packaging EMA SPORdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000004 Pharmaceutical Dose Form EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000005003 Record Status EMA SPORdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000072049 Regulatory Entitlement Status EMA SPORdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000073345 Routes and Methods of Administration EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v2/SubstanceDefinition Substances EMA SPOR SMSdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000110633 Unit of Measurement EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000014 Unit of Presentation EMAdraft2024-10
hl7.eu.fhir.unicomR5ConceptMap/edqm-ema-pharmaceuticalDoseForm-cm EDQM-SPOR Pharmaceutical dose formsdraft2024-10
hl7.eu.fhir.unicomR5ConceptMap/sms-snomed-substance-cm SPOR-SNOMED CT substancesdraft2024-10
hl7.eu.fhir.unicomR5ImplementationGuide/hl7.eu.fhir.unicom UnicomIGdraft2024-10
hl7.eu.fhir.unicomR5OperationDefinition/Equivalent Equivalent Look Upactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/Manufactured-item-packaging-ppd manufactured-item-packaging-ppdactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/Manufactured-item-ppd manufactured-item-ppdactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/country countryactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/name-language-correct name-language-correctactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/reference-strength-substance reference-strength-substanceactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/strength-presentation-quantity strength-presentation-quantityactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/strength-presentation-ratio-denominator strength-presentation-ratio-numeratoractive2024-10
hl7.eu.fhir.unicomR5SearchParameter/strength-presentation-ratio-numerator strength-presentation-ratio-numeratoractive2024-10
hl7.eu.fhir.unicomR5SearchParameter/strength-presentation-ratio strength-presentation-ratioactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/strength-quantity-and-substance strength-quantity-and-substanceactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/strength-ratio-and-substance strength-ratio-and-substanceactive2024-10
hl7.eu.fhir.unicomR5StructureDefinition/AD ADdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/ANY ANYdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/BL BLdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/CD CDdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/Class Classdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/CrossBorderProduct DRAFT: Medicinal Product in crossborder eP/eDdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/DT DTdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/EN ENdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/FullMedicinalProduct Medicinal Product Logical Modeldraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/II IIdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/INT INTdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/ManufacturedMaterial DRAFT: MyHealth@EU medicinal productdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/MedicationAsManufacturedItem Medication as manufactured itemdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/MedicationAsMedicinalProduct Medicationdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/MedicationModel Medication for clinical workflowsdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLAdministrableProductDefinition PPL Administrable Product profiledraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLIngredient PPL Ingredient profiledraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLManufacturedItemDefinition PPL Manufactured Item profiledraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLMedicinalProductDefinition PPL Medicinal Product profiledraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLOrganization PPL Organizationdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLPackagedProductDefinition PPL Packaged Product profiledraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLRegulatedAuthorization PPL Marketing Authorisation profiledraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PQ PQdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/REAL REALdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/RTO RTOdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/ST STdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/SctClinicalDrug SNOMED CT Clinical Drugdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TS TSdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionAdministrableProductDefinition Processing Profile - Administrable Productdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionIngredient Processing Profile - Ingredientdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionManufacturedItemDefinition Processing Profile - Manufactured Itemdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionMedicinalProductDefinition Processing Profile - Medicinal Productdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionOrganization Processing Profile - Organizationdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionPackagedProductDefinition Processing Profile - Packaged Productdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionRegulatedAuthorization Processing Profile - Marketing Authorisationdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/Untyped Untypeddraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/administrable-doseform AdministrableDoseFormdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/medicinal-product-classification MedicinalProductClassificationdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/medicinal-product-name MedicinalProductNamedraft2024-10
hl7.eu.fhir.unicomR5ValueSet/administration-device EDQM Administration Deviceactive2024-10
hl7.eu.fhir.unicomR5ValueSet/administration-method EDQM Administration Methodactive2024-10
hl7.eu.fhir.unicomR5ValueSet/all-units-vs EMA SPOR All Units Combineddraft2024-10
hl7.eu.fhir.unicomR5ValueSet/atc-spor-vs EMA SPOR ATCdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/authorised-doseform-vs EMA SPOR Authorised Dose Formdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/basic-dose-form EDQM Basic Dose Formactive2024-10
hl7.eu.fhir.unicomR5ValueSet/closure EDQM Closureactive2024-10
hl7.eu.fhir.unicomR5ValueSet/combination-pack EDQM Combination Packactive2024-10
hl7.eu.fhir.unicomR5ValueSet/combined-pharmaceutical-dose-form EDQM Combined Pharmaceutical Dose Formactive2024-10
hl7.eu.fhir.unicomR5ValueSet/combined-term EDQM Combined Termactive2024-10
hl7.eu.fhir.unicomR5ValueSet/container EDQM Containeractive2024-10
hl7.eu.fhir.unicomR5ValueSet/country-ema-vs EMA SPOR Countrydraft2024-10
hl7.eu.fhir.unicomR5ValueSet/country-iso-vs Country (ISO 3166-1-2)draft2024-10
hl7.eu.fhir.unicomR5ValueSet/domain-vs EMA SPOR Domaindraft2024-10
hl7.eu.fhir.unicomR5ValueSet/ehdsi-ucum-unit MyHealth@EU Unit of Measurement (UCUM)active2024-10
hl7.eu.fhir.unicomR5ValueSet/intended-site EDQM Intended Siteactive2024-10
hl7.eu.fhir.unicomR5ValueSet/language-bcp-vs Language (FHIR)draft2024-10
hl7.eu.fhir.unicomR5ValueSet/language-ema-vs EMA SPOR Languagedraft2024-10
hl7.eu.fhir.unicomR5ValueSet/legal-status-for-the-supply-vs EMA SPOR Legal Status for the Supplydraft2024-10
hl7.eu.fhir.unicomR5ValueSet/marketing-status-spor-vs EMA SPOR Marketing Statusdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/material-vs EMA SPOR Materialdraft2024-10

XIG built as of 17 Dec 2024. Found 40236 resources in 710 packages.